Russell Investments Group’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-193
Closed -$6.43K 3850
2024
Q3
$6.43K Sell
193
-409
-68% -$14.1K ﹤0.01% 3171
2024
Q2
$16.3K Buy
602
+582
+2,910% +$11.5K ﹤0.01% 2978
2024
Q1
$432 Buy
+20
New +$436 ﹤0.01% 3224

Russell Investments Group's LBPH Position: Q4 2024 in Review

Russell Investments Group sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 193 shares — an estimated $6.43K sold.

Russell Investments Group first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $16.3K in Q2 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Russell Investments Group reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Russell Investments Group sold 193 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $6.43K.
  • Russell Investments Group first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • Russell Investments Group's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $16.3K in Q2 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Russell Investments Group's 13F filing for Q4 2024, filed 13 Feb 2025.